PET Radiotracer Market Pegged for Robust Expansion by 2026

Radiotracers used in Positron Emission Tomography (PET) are chemical compounds comprising more than one atom replaced by a radioisotope. PET radiotracers market are administered intravenously. Radiotracers are used for tracking the mechanism of chemical reaction taking part in a biological system, such as, glucose metabolism, amino acid uptake, glucocorticoid synthesis, and other metabolic studies. There are several types of radiotracers used in PET for metabolic studies for visualization using PET imaging.

The IAEA (International Atomic Energy Agency) plays an important role in assisting the transfer of radiotracer technology to developing member states. The organization helps member states in the development of human resources, education, and in maintaining good practices to ensure the sustainability of knowledge transfer and technology. The commonly used PET radiotracers for imaging are F 18 FDG, C-11 Methionine, F 18 fluoroethyl-l-tyrosine (FET), F 18 fluoro-dihydroxy-l-phenylalanine (F-DOPA), and C 11 Etomidate. The half-life period for a radiotracer varies from approximately 20 minutes to nearly 120 minutes.

Request Brochure of PET Radiotracer Market Report

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=48576

According to the American Nuclear Society, more than 10,000 hospitals throughout the world use radioisotopes, and approximately 90% of these are used for the diagnosis of infectious diseases, cancer, neurological disorders, and other diagnostic applications, allowing for cerebral blood flow visualization, tumor protein synthesis, neuroendocrine imaging, myocardial perfusion, and other studies.

Key drivers of the PET radiotracer market are increasing incidence rate of cancer and neurological disorders across the world. According to the CBTRUS (Central Brain Tumor Registry of the U.S.), glioma accounts for approximately 27% of all forms of brain tumors and nearly 80% of malignant tumors. Other drivers of the PET radiotracer market are increasing research and development activities, rising government initiatives to promote health care facilities, technological advancements in nuclear imaging, and increasing product approvals.

Major companies operating in the global PET radiotracer market include Alliance Medical, Cambridge Isotope Laboratories, Inc., IBA, ABX GmbH, and PETNET Solutions, Inc.

Leave a Reply

Your email address will not be published. Required fields are marked *